Posts in Video
How do you know if your cancer is ALK-positive?

Dr. Ross Camidge explains how a lung cancer patient knows if they have ALK-positive lung cancer. ALK is an important biomarker that can impact lung cancer treatment options. Talk to your doctor about comprehensive biomarker testing.

Visit Lung.org/alk for more information. Support for this educational program provided by Amgen, AstraZeneca, Blueprint Medicines, Bristol Myers Squibb, Genentech, Lilly Oncology, Merck, Novartis and Pfizer.
WATCH VIDEO

American Lung Association
Authors:
Dr. Ross Camidge

Read More
VideoKirk SmithALK, biomarker
What is treatment like for ALK-positive lung cancer?

Dr. Ross Camidge explains the treatment options for ALK-positive lung cancer. ALK is an important biomarker that can impact lung cancer treatment options. Talk to your doctor about comprehensive biomarker testing. Visit Lung.org/alk for more information. Support for this educational program provided by Amgen, AstraZeneca, Blueprint Medicines, Bristol Myers Squibb, Genentech, Lilly Oncology, Merck, Novartis and Pfizer.
WATCH VIDEO

American Lung Association

Authors: Dr. Ross Camidge

Read More
Dr Nemenoff and Colin Barton post Summit interview

ALK Positive awarded a $200,000 grant in 2018 to Dr Raphael Nemenoff to research new ways to better treat ALK- positive lung cancer. Dr Nemenoff is a leading researcher at the University of Colorado, working with Dr Ross Camidge, a world-leading ALK lung cancer expert and thoracic oncologist. Dr Colin Barton was diagnosed with ALK-positive lung cancer in 2016, and is Chair of the ALK Positive Medical Committee. Here, on August 14, 2020, Colin interviews Dr Nemenoff. Dr. Nemenoff discusses his research and the human immune system and specifically the complement system. WATCH VIDEO

ALK Positive Inc.

Authors: Dr. Nemenoff

Read More